Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice

World Journal of Gastroenterology

Volumn 17, Issue 48, 2011, Pages 5267-5273

  Lv, Xin ^a,b   Song, Jian Gang ^a   Li, Hong Hai ^a   Ao, Jun Ping ^a   Zhang, Ping ^a   Li, Ye Sheng ^c   Song, Shao Li ^a   Wang, Xiang Rui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endotoxemia; Liver; Obstructive jaundice; Peroxisome proliferator activated receptor y; Rosiglitazone

Indexed keywords

ALANINE AMINOTRANSFERASE; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; DISEASE PREDISPOSITION; DOWN REGULATION; ENDOTOXEMIA; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RAT; SURVIVAL; WESTERN BLOTTING;

EID: 84455192871     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i48.5267     Document Type: Article

References (39)

1. Ingoldby CJ, McPherson GA, Blumgart LH. Endotoxemia in human obstructive jaundice. Effect of polymyxin B. Am J Surg 1984; 147: 766-771
2. Hunt DR, Allison ME, Prentice CR, Blumgart LH. Endotox-emia, disturbance of coagulation, and obstructive jaundice. Am J Surg 1982; 144: 325-329
3. Pain JA, Bailey ME. Measurement of operative plasma en-dotoxin levels in jaundiced and non-jaundiced patients. Eur Surg Res 1987; 19: 207-216
4. Kocsár LT, Bertók L, Várterész V. Effect of bile acids on the intestinal absorption of endotoxin in rats. J Bacteriol 1969; 100: 220-223
5. Bailey ME. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg 1976; 63: 774-778
6. Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 1990; 159: 79-84
7. Van Bossuyt H, Desmaretz C, Gaeta GB, Wisse E. The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat. J Hepatol 1990; 10: 274-279
8. Pitt HA, Cameron JL, Postier RG, Gadacz TR. Factors affecting mortality in biliary tract surgery. Am J Surg 1981; 141: 66-72
9. Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. Gastroenterology 1990; 98: 478-485
10. Sewnath ME, Van Der Poll T, Ten Kate FJ, Van Noorden CJ, Gouma DJ. Interleukin-1 receptor type I gene-defcient bile duct-ligated mice are partially protected against endotoxin. Hepatology 2002; 35: 149-158
11. Lechner AJ, Velasquez A, Knudsen KR, Johanns CA, Tracy TF, Matuschak GM. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. Am J Respir Crit Care Med 1998; 157: 1550-1558
12. Nehéz L, Andersson R. Compromise of immune function in obstructive jaundice. Eur J Surg 2002; 168: 315-328
13. Kennedy JA, Clements WD, Kirk SJ, McCaigue MD, Campbell GR, Erwin PJ, Halliday MI, Rowlands BJ. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg 1999; 86: 628-633
14. Kennedy JA, Lewis H, Clements WD, Kirk SJ, Campbell G, Halliday MI, Rowlands BJ. Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction. Br J Surg 1999; 86: 1410-1414
15. von Knethen A, Soller M, Brüne B. Peroxisome proliferator-activated receptor gamma (PPAR gamma) and sepsis. Arch Immunol Ther Exp (Warsz) 2007; 55: 19-25
16. Andersen V, Christensen J, Ernst A, Jacobsen BA, Tjønneland A, Krarup HB, Vogel U. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of infammatory bowel disease. World J Gastroenterol 2011; 17: 197-206
17. Zhou M, Wu R, Dong W, Jacob A, Wang P. Endotoxin down-regulates peroxisome proliferator-activated receptor-gamma via the increase in TNF-alpha release. Am J Physiol Regul In-tegr Comp Physiol 2008; 294: R84-R92
18. Papakostas C, Bezirtzoglou E, Pitiakoudis M, Polychronidis A, Simopoulos C. Endotoxinemia in the portal and the systemic circulation in obstructive jaundice. Clin Exp Med 2003; 3: 124-128
19. Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cyto-kines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992; 15: 1132-1136
20. Pain JA. Reticulo-endothelial function in obstructive jaundice. Br J Surg 1987; 74: 1091-1094
21. Bemelmans MH, Greve JW, Gouma DJ, Buurman WA. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. Gut 1996; 38: 447-453
22. Nomura T, Shirai Y, Hatakeyama K. Impact of bactibilia on the development of postoperative abdominal septic complications in patients with malignant biliary obstruction. Int Surg 1999; 84: 204-208
23. Thompson JN, Edwards WH, Winearls CG, Blenkharn JI, Benjamin IS, Blumgart LH. Renal impairment following biliary tract surgery. Br J Surg 1987; 74: 843-847
24. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191: 38-46
25. Pain JA, Cahill CJ, Bailey ME. Perioperative complications in obstructive jaundice: therapeutic considerations. Br J Surg 1985; 72: 942-945
26. Hoffmann R, Grewe M, Estler HC, Schulze-Specking A, Decker K. Regulation of tumor necrosis factor-alpha-mRNA synthesis and distribution of tumor necrosis factor-alpha-mRNA synthesizing cells in rat liver during experimental endotox-emia. J Hepatol 1994; 20: 122-128
27. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte infammatory cytokines. Nature 1998; 391: 82-86
28. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The per-oxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82
29. Collin M, Patel NS, Dugo L, Thiemermann C. Role of peroxi-some proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. Crit Care Med 2004; 32: 826-831
30. Abdelrahman M, Collin M, Thiemermann C. The peroxi-some proliferator-activated receptor-gamma ligand 15-de-oxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. Shock 2004; 22: 555-561
31. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Fulia F, Cuzzocrea E, Di Rosa M, Caputi AP, Thiemermann C. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zy-mosan in mice. Crit Care Med 2004; 32: 457-466
32. Zingarelli B, Sheehan M, Hake PW, O'Connor M, Denen-berg A, Cook JA. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic infammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 2003; 171: 6827-6837
33. Liu D, Zeng BX, Shang Y. Decreased expression of peroxi-some proliferator-activated receptor gamma in endotoxin-induced acute lung injury. Physiol Res 2006; 55: 291-299
34. Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, Simms HH, Wang P. The anti-infammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med 2006; 34: 1874-1882
35. Higuchi S, Wu R, Zhou M, Ravikumar TS, Wang P. Down-regulation of hepatic cytochrome P-450 isoforms and PPAR-gamma: their role in hepatic injury and proinflammatory responses in a double-hit model of hemorrhage and sepsis. J Surg Res 2007; 137: 46-52
36. Kaplan JM, Cook JA, Hake PW, O'Connor M, Burroughs TJ, Zingarelli B. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. Shock 2005; 24: 59-65
37. Vish MG, Mangeshkar P, Piraino G, Denenberg A, Hake PW, O'Connor M, Zingarelli B. Proinsulin c-peptide exerts benef-cial effects in endotoxic shock in mice. Crit Care Med 2007; 35: 1348-1355
38. Hill MR, Young MD, McCurdy CM, Gimble JM. Decreased expression of murine PPARgamma in adipose tissue during endotoxemia. Endocrinology 1997; 138: 3073-3076
39. Feingold K, Kim MS, Shigenaga J, Moser A, Grunfeld C. Altered expression of nuclear hormone receptors and coacti-vators in mouse heart during the acute-phase response. Am J Physiol Endocrinol Metab 2004; 286: E201-E207